← All candidates
114 insider filings on record.
114 filings on record.
GDRXGoodRx Holdings, Inc.
NasdaqGS · Healthcare · $1.19B
$3.49
-1.97% · Sep 15
114 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 16 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.19B
Float
94.0M
88% public
Short % float
Pro
Price / profit
58.2
Price / future profit
9.8
Price / sales
1.5
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
109 more transactions on Pro →Context
Wall St
$4.03 avg target
+15.5% vs today · 13 analysts · consensus Hold
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q2 '26$0.08 act+$0.00
Q1 '26$0.07 act−$0.00
Q4 '25$0.09 act−$0.00
Q3 '25$0.08 act−$0.01
Coverage
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)StockStory · 08-14GoodRx (GDRX) Stock Looks Overvalued On Its Earnings OutlookSimply Wall St. · 08-13GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance RaiseSimply Wall St. · 08-13GoodRx (GDRX) Q2 2026 Earnings Call TranscriptMotley Fool · 08-12
The file stays open
114 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice